Theglobal 'oncology drugs market' size isexpected to reach USD 394.24 billion by 2027, exhibiting a CAGR of 11.6% duringthe forecast period. The growing prevalence of cancer around the world willspur opportunities for this market during the forecast period, states FortuneBusiness Insights, in a report, titled “Oncology Drugs Market Size, Share&COVID-19 Impact Analysis, By Drugs Class (Cytotoxic Drugs, Targeted Drugs,Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, andImmunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer,Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid, Liquid, andInjectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies,Online Pharmacies, Others), and Regional Forecast, 2020-2027.” The market sizestood at USD 141.33 billion in 2019.
Frequently Ask Question :
1) How much is the oncology drugsmarket worth?
Fortune Business Insights says that the global oncology drugs marketsize was USD 141.33 billion in 2019 and is projected to reach USD 394.24billion by 2027.
2) What was the value of themarket in North America in 2019?
In 2019, the North America market value stood at USD 65.63 billion.
3) At what CAGR is the marketprojected to grow in the forecast period (2020-2027)?
Growingat a CAGR of 11.6%, the market will exhibit steady growth in the forecastperiod (2020-2027).
An Overview of the Impact of COVID-19 on this Market :
Theemergence of COVID-19 has brought the world to a standstill. We understand thatthis health crisis has brought an unprecedented impact on businesses acrossindustries. However, this too shall pass. Rising support from governments andseveral companies can help in the fight against this highly contagious disease.There are some industries that are struggling and some are thriving. Overall,almost every sector is anticipated to be impacted by the pandemic.
Weare taking continuous efforts to help your business sustain and grow duringCOVID-19 pandemics. Based on our experience and expertise, we will offer you animpact analysis of corona virus outbreak across industries to help you preparefor the future.
The oncology drugs market highlights:
- An extensivestudy of regions
- Forecast value of the market
- Detailed analysis ofthe segments
- COVID-19 effect on the market
- Ongoing clinical trials
Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/oncology-drugs-market-103431
Positive Impact on Oncology Drugs Market Growth During COVID-19
Theoutbreak of COVID-19 has had a positive impact on the oncology drugs marketglobally. Certain market segments have witnessed a growth in demand for drugswith respect to the COVID-19 emergency. Panic buying of medications has beenwitnessed among the cancer patients amid lockdown. The pharmaceutical companiesinvolved in this market have significantly improved their supply chainmanagement, enhanced the capabilities of their R&D, and invested more theirmanufacturing management and quality control. For instance, according to thequarterly reports of 2020 of Roche, their global supply chain of medicines andtests remain intact and their pharmaceutical division sales increased by 7% ascompared to the prior year.
Market Driver:
Surging Pharmaceutical Industry to Contribute Colossal Development
Theongoing technological advancement in the field of pharmacy is expected tocreate opportunities for the market during the forecast period. The clinicaltrials and various drugs in the pipeline can further facilitate the healthygrowth of the industry. The growing cases of numerous types of cancer, such aslung cancer, skin cancer, prostate cancer, colon cancer, breast cancer, andothers will spur demand for oncology drugs, thus enhancing market growth.According to the World Health Organization (WHO), cancer is a growing burden andthe number of new cancer cases is going to rise from 18.1 million in 2018 to29.4 million by 2040. Moreover, product launches and approvals are expected tohave a tremendous impact on the market.
Positive Impact on Oncology Drugs Market Growth During COVID-19
Theoutbreak of COVID-19 has had a positive impact on the oncology drugs marketglobally. Certain market segments have witnessed a growth in demand for drugswith respect to the COVID-19 emergency. Panic buying of medications has beenwitnessed among the cancer patients amid lockdown. The pharmaceutical companiesinvolved in this market have significantly improved their supply chainmanagement, enhanced the capabilities of their R&D, and invested more theirmanufacturing management and quality control. For instance, according to thequarterly reports of 2020 of Roche, their global supply chain of medicines andtests remain intact and their pharmaceutical division sales increased by 7% ascompared to the prior year.
For more information visit : https://www.fortunebusinessinsights.com/oncology-drugs-market-103431
Table Of Content :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Key Indications (Lung Cancer, Breast Cancer, Prostate Cancer, etc.), By Region/Country
- Overview of Different Oncology Drugs with respect to Regulatory Approvals and Clinical Trials
- Pricing Analysis, By Key Players
- Recent Advancements in Development of Oncology Drugs
- Key Industry Developments (Mergers, Acquisitions, and Partnerships)
- Impact of COVID-19 on Oncology Drugs Market
- Global Oncology Drugs Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Cytotoxic Drugs
- Alkylating Agents
- Antimetabolites
- Others
- Targeted Drugs
- Monoclonal Antibodies
- Others
- Hormonal Drugs
- Others
- Market Analysis, Insights and Forecast – By Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Market Analysis, Insights and Forecast – By Indication
- Lung Cancer
- Stomach Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Others
- Market Analysis, Insights and Forecast – By Dosage Form
§ Solid
§ Tablets
§ Capsules
- Liquid
- Injectable
- Prefilled Syringes
- Others
- Market Analysis, Insights and Forecast- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Regional Analysis:
Rising Prevalence to Cancer to Influence Market in North America
Themarket size in North America is expected to witness a rapid growth rate duringthe forecast period. The dominance in the region is attributed to the growingprevalence of cancer in the U.S. As per the National Cancer Institute, in 2020,approximately 1.8 million people will be diagnosed with cancer in the U.S. Therecent product launches will aid the expansion of the market in the region.Europe is predicted to exhibit a stellar growth rate during the forecast periodowing to the growing cancer burden in countries such as U.K., Germany, andFrance. The market in Asia Pacific is predicted to rise tremendously during theforecast period due to the rising awareness among the population regardingcancer.
Key Development:
April 2019: Sun Pharmaceutical Industriesannounced the release of INFUGEM injection, which will ve used for thetreatment of cancer in the US.
The Report Lists the Main Companies in the Market:
- Hoffmann-La Roche Ltd (Basel, Switzerland)
- Genentech, Inc. (California, United States)
- Novartis AG (Basel, Switzerland)
- Pfizer Inc. (New York, United States)
- Bristol-Myers Squibb Company (New York, United States)
- GlaxoSmithKline plc. (Brentford, United Kingdom)
- Eli Lilly and Company (Indiana, United States)
- AstraZeneca (Cambridge, United Kingdom)
- Sanofi (Paris, France)
- Bayer AG (Leverkusen, Germany)
- Other Players
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/oncology-drugs-market-103431
Global Oncology Drugs Market Segmentation :
By Drug Class
- Cytotoxic Drugs
· Alkylating Agents
· Antimetabolites
· Others
- Targeted Drugs
· Monoclonal Antibodies
· Others
- Hormonal Drugs
- Others
By Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
By Indication
- Lung Cancer
- Stomach Cancer
- Colorectal Cancer
- Breast Cancer
- Prostate Cancer
- Others
By Dosage Form
- Solid
· Tablets
· Capsules
- Liquid
- Injectable
· Prefilled Syringes
· Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Geography
- North America (the U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)
Related Reports:
About Us:
Fortune Business Insights(TM) offers expert corporate analysis and accuratedata, helping organizations of all sizes make timely decisions. We tailorinnovative solutions for our clients, assisting them to address challengesdistinct to their businesses. Our goal is to empower our clients with holisticmarket intelligence, giving a granular overview of the market they areoperating in.
Our reports contain a unique mix of tangible insights and qualitative analysisto help companies achieve sustainable growth. Our team of experienced analystsand consultants use industry-leading research tools and techniques to compilecomprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrativegrowth opportunities for our clients. We, therefore, offer recommendations,making it easier for them to navigate through technological and market-relatedchanges. Our consulting services are designed to help organizations identifyhidden opportunities and understand prevailing competitive challenges
Contact Us:
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
